Tag: RNA

Tuesday’s Recaps, Today’s Fresh Ideas

Recap For Tuesday Plays:

While the markets certainly pulled a head fake yesterday, stair-stepping down for the majority of the session after an early morning gap-up, we still managed to see some marginal gain opportunities in the daily options ideas we put in yesterday’s premarket report. While the gain chances in the SPY and others were slightly muted compared to what we usually achieve, our FLNC Calls clearly stole the show with an excellent multibag performance.

Our specific areas of interest for Tuesday were the SPY 12/13 $407-410 Calls, the ORCL Weekly $82.50-85 Calls, the CNM Weekly $22.50 Calls, and the FLNC Weekly $17.50 Calls. The rundown of the moves they and the total possible profits associated with those, were as follows:

SPY 12/13 $407-410 Calls
$407: 2.40-3.88 (+62%)
$408: 1.88-3.16 (+68%)
$409: 1.47-2.53 (+72%)
$410: 1.12-1.97 (+76%)
_____

ORCL Weekly $82.50-85 Calls
$82.50: .34-.52 (+53%)
$83:.26-.45 (+73%)
$84: .15-.30 (+100%)
$85: .10-.19 (+90%)

CNM Weekly $22.50 Calls
$22.50: .20-.35 (+75%)

FLNC Weekly $17.50 Calls
$17.50: 1.95-5.50 (+182%)

Fresh Options Ideas:
STNG Weekly $55 Calls
PLUG Weekly $14-15 Calls 

Extended Watchlist:
VIZC, ZCTSF, HNRC, ADHC, UATG, MAPT, NBLD, VLON, MLGO, CRKN, IMMX, KYMR, RNA

Excellent Options Movers

Exciting Options Activity

We’ve been having an excellent week for options, and saw some new highs in the PTON Calls we submitted in Tuesday morning’s report, as well as some nice activity out of the starting gate for a couple of our fresh options ideas. We went to the short side on EA and long on CLVS, and in both cases we were able to reap instant rewards.

PTON Weekly $34-35 Calls
$34: 2.96-6.10 (+106%)
$35: 2.41-5.40 (+124%)

Just as we mentioned yesterday, we expect to see these PTON gains increased today, based on premarket activity in the stock. We’re also going to include the PTON 05/15 $42-44 Calls in our watchlist. 
_____

EA Weekly $120-115 Puts
$120: 4.03-7.73 (+92%)
$119: 3.00-7.00 (+133%)
$118: 2.40-5.07 (+111%)
$117: 1.88-5.00 (+166%)
$116: .95-4.00 (+321%)
$115: 1.34-3.50 (+161%)
_____

CLVS Weekly $8-8.50 Calls 
$8: .55-1.35 (+145%)
$8.50: .25-.90 (+260%)


Fresh Ideas:
VIAC Weekly $16-18 Calls
FVRR 05/15 $45-55 Calls
MRNA Weekly $53.50-55 Calls
PYPL Weekly $135-145 Calls

Extended Watchlist:
BTCS, BLXX, OSTK, BSGM, TEAR, INTV, WNDW, SPOM

Blue Horseshoe Stocks: Commenting on PBR & More

Petroleo Brasiliero S.A. (Petrobras) PBR

Amid allegations of money-laundering and bribery which extend high up into the Brazilian government (including former PBR board member and President Dilma Rousseff) the sixth-largest energy company in the world, and a point of focus for us all year, could be forced to write down billions in assets and reduce dividends. The company’s Q3 financials are being delayed indefinitely as a result.

The long-term implications of such a scandal are too vast and varied for us to make even a brief assessment accurately. What we can do is stay extra tuned to the PBR newsfeed to stay as up-to-date as possible on current events and adhere to our technicals, because we can still see potential on the chart.

On Tuesday, PBR hit its all-time low of 8.80. but has since made higher lows and higher highs over the proceeding sessions. After we tagged it on Friday morning, there was a 9% intraday move from 10.08 to $11, and this morning the premarket high is 11.51, which will act as immediate resistance as the session kicks off. We’ll want to see support hold at roughly 10.85, but if PBR can break past this morning’s high to confirm its continued uptrend, the next thing we’d be looking for is the filling of a gap on the chart from approximately $12-12.50.

As far as options go, we’re presently looking at the Jan 17th $10 and $11 Calls, provided the current trend continues.

Prosensa Holdings (N.V.) RNA

RNA is a stock that we tracking periodically this spring and summer, and we just wanted to comment quickly on the buyout offer the company announced this morning. In a $680M deal, Prosensa will receive around $17.75/share from buyer BioMarin Pharmaceutical.

Following an alert we put out on RNA back in May, the stock was trading at a low of 7.96; this morning’s premarket high of $19 means we’ve seen more than a 130% move in this play over a span of about 5 months.

Extended Watchlist:
MOLG, GERN, CIMT, SYN, AEMD, MY